Efficacy News and Research

RSS
Researchers develop a polyvalent lipid nanoparticle mRNA vaccine against Monkeypox virus

Researchers develop a polyvalent lipid nanoparticle mRNA vaccine against Monkeypox virus

Researchers uncover the host protease CAPN2 as a novel host factor that aids the infection of SARS-CoV-2

Researchers uncover the host protease CAPN2 as a novel host factor that aids the infection of SARS-CoV-2

Trial shows acoziborole drug clears body of African sleeping sickness parasites

Trial shows acoziborole drug clears body of African sleeping sickness parasites

Researchers develop potent yet low-inflammatory mRNA cancer vaccine vectors

Researchers develop potent yet low-inflammatory mRNA cancer vaccine vectors

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

Exploring the effects of dietary fiber on gut microbiome and inflammatory diseases

Exploring the effects of dietary fiber on gut microbiome and inflammatory diseases

Vaccination against pertussis in pregnancy and outstanding scientific questions

Vaccination against pertussis in pregnancy and outstanding scientific questions

Collaborative work unravels hidden molecular secrets of age-related diseases

Collaborative work unravels hidden molecular secrets of age-related diseases

The business of clinical trials is booming. Private equity has taken notice.

The business of clinical trials is booming. Private equity has taken notice.

Scaling up the production of customized immune cells for drug development and testing

Scaling up the production of customized immune cells for drug development and testing

Study implicates gut microbiome health in Parkinson's disease

Study implicates gut microbiome health in Parkinson's disease

Using cationic nanonmaterials to target visceral adiposity

Using cationic nanonmaterials to target visceral adiposity

Gargling with povidone-iodine may reduce salivary viral load in COVID-19 patients

Gargling with povidone-iodine may reduce salivary viral load in COVID-19 patients

Very low-calorie and vegan diets improve glycemic control in type 2 diabetes

Very low-calorie and vegan diets improve glycemic control in type 2 diabetes

Prior infection and vaccination protects against severe outcomes from SARS-CoV-2 Omicron infection

Prior infection and vaccination protects against severe outcomes from SARS-CoV-2 Omicron infection

HU begins human trial for promising treatment to reverse paralysis and language disorder after stroke

HU begins human trial for promising treatment to reverse paralysis and language disorder after stroke

Phase 2 clinical trial of DS-1211 begins for individuals with Pseudoxanthoma Elasticum

Phase 2 clinical trial of DS-1211 begins for individuals with Pseudoxanthoma Elasticum

Risk factor assessment for the development of severe SARS-CoV-2 breakthrough infections

Risk factor assessment for the development of severe SARS-CoV-2 breakthrough infections

Novel prefusion S antigen designed by the mutation of the SARS-CoV-2 Spike protein’s trimeric structure

Novel prefusion S antigen designed by the mutation of the SARS-CoV-2 Spike protein’s trimeric structure

Researchers explore failed SARS-CoV-2 screening at hospital entrances

Researchers explore failed SARS-CoV-2 screening at hospital entrances

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.